Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PhaseRx Inc (PZRXQ)
OTHER OTC:PZRXQ
PhaseRx (PZRXQ) Stock Price & Analysis
24 Followers
PZRXQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $0.09
Previous Close$0.05
Volume3.00
Average Volume (3M)N/A
Market Cap
$2.34K
Enterprise Value$186.34K
Total Cash (Recent Filing)$5.26M
Total Debt (Recent Filing)$5.44M
Price to Earnings (P/E)N/A
Beta-1.40
Next Earnings
Aug 05, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.73
R-Squared0.00002
Alpha0.13
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
0.00%
Insiders
0.00%
Mutual Funds
0.45% Other Institutional Investors
99.55% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PZRXQ FAQ
What was PhaseRx Inc’s price range in the past 12 months?
PhaseRx Inc lowest stock price was $0.00 and its highest was $0.09 in the past 12 months.
What is PhaseRx Inc’s market cap?
Currently, no data Available
When is PhaseRx Inc’s upcoming earnings report date?
PhaseRx Inc’s upcoming earnings report date is Aug 05, 2019 which is 1726 days ago.
How were PhaseRx Inc’s earnings last quarter?
Currently, no data Available
Is PhaseRx Inc overvalued?
According to Wall Street analysts PhaseRx Inc’s price is currently Overvalued.
Does PhaseRx Inc pay dividends?
PhaseRx Inc does not currently pay dividends.
What is PhaseRx Inc’s EPS estimate?
PhaseRx Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PhaseRx Inc have?
PhaseRx Inc has 11,690,000 shares outstanding.
What happened to PhaseRx Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PhaseRx Inc?
Currently, no hedge funds are holding shares in PZRXQ
---
Company Description
PhaseRx Inc
PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency; argininosuccinate lyase deficiency; and argininosuccinate synthetase deficiency. The company was founded by Robert W. Overell, Patrick S. Stayton, Allan S. Hoffman, Oliver W. Press, and Paul H. Johnson on March 9, 2006 and is headquartered in Seattle, WA.
---
Technical Analysis
---